[1] Wang F, Yang C, Long J, et al. Executive summary for the 2015 Annual Data Report of the China Kidney Disease Network(CKNET)[J]. Kidney Int, 2019, 95(3):501-505.
[2] Murea M, Geary RL, Davis RP, et al. Vascular access for hemodialysis:A perpetual challenge[J]. Semin Dial, 2019, 32(6):527-534.
[3] Brahmbhatt A,Remuzzi A,Franzoni M,et al.The molecular mechanisms of hemodialysis vascular access failure[J].Kidney Int,2016,89(2):303-316．
[4] Braga SF, Neves JR, Ferreira J,et al. Neointimal Hyperplasia[J].Rev Port Cir Cardiotorac Vasc. 2019;26(3):213-217.
[5] Brahmbhatt A, Remuzzi A, Franzoni M, et al. The molecular mechanisms of hemodialysis vascular access failure[J]. Kidney Int. 2016,89(2):303-316.
[6] Weifeng Li et al. Cinnamaldehyde protects VSMCs against ox-LDL-induced proliferation and migration through S arrest and inhibition of p38, JNK/MAPKs and NF-κB[J].Vascul Pharmacol. 2018;108:57-66.
[7] Kyung Jong Won et al. Desalted Salicornia europaea extract attenuated vascular neointima formation by inhibiting the MAPK pathway-mediated migration and proliferation in vascular smooth cells muscle [J]. Biomedicine & Pharmacot herapy, 2017, 94 : 430-438.
[8] Liu E, Shi S, Li J, et al. Farrerol maintains thecontractile phenotype of VSMCs via inactivating the extracellularsignal-regulated protein kinase 1/2 and p38 mitogen-activatedprotein kinase signaling[J].Mol Cell Biochem.2020,475(1-2):249-260.
[9] Sun Y, Liu WZ, Liu T,et al. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis[J]. J Recept Signal Transduct Res.2015;35(6):600-4.
[10] Kyriakis JM, Avruch J. Mammalian MAPK signal transduction pathways activated by stress and inflammation:a 10-year update[J]. Physiol Rev. 2012 Apr;92(2):689-737.
[11] JL Brewster,T de Valoir,ND Dwyer,E Winter,and MC Gustin.An osmosensing signal transduction pathway in yeast [J].Science ,1993 ,259 (5102) :1760-1763.
[12] Cuadrado A, Nebreda AR. Mechanisms and functions of p38 MAPK signalling. Biochem [J]. 2010 Aug 1;429(3):403-17.
[13] Reustle Anna and Torzewski Michael. Role of p38 MAPK in Atherosclerosis and Aortic Valve Sclerosis[J]. Int J Mol Sci. 2018;19(12):3761.
[14] Schett G, Zwerina J, Firestein G. The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis[J].?Ann Rheum Dis. 2008;67(7):909-916.
[15] Timmy Lee and Naveed Ul Haq. New Developments in Our Understanding of Neointimal Hyperplasia[J]. Advances in Chronic Kidney Disease, 2015, 22(6) : 431-437.
[16] Frismantiene A, Philippova M, Erne P, et al. Smooth muscle cell-driven vascular diseases and molecular mechanisms ofVSMC plasticity[J]. Cell Signal. 2018 Dec;52:48-64.
[17] Zhao J, Jourd'heuil FL, Xue M, Conti D, et al. Dual Function for Mature Vascular Smooth Muscle Cells During Arteriovenous Fistula Remodeling[J]. Am Heart Assoc. 2017 Mar30;6(4):e004891.
[18] Shi J, Yang Y, Cheng A, et al. Metabolism of vascular smooth muscle cells in vascular diseases[J].?Am J Physiol Heart Ci rc Physiol. 2020;319(3):H613-H631
[19] Zhang YN, Xie BD, Sun L, et al. Phenotypic switching of vascular smooth muscle cells in the 'normal region' of aorta from atherosclerosis patients is regulated by miR-145[J]. Cell Mol Med. 2016;20(6):1049-1061.
[20] Liu E, Shi S, Li J, et al. Farrerol maintains the contractile phenotype of VSMCs via inactivating the extracellular signal-regulated protein kinase 1/2 and p38 mitogen-activated protein kinase signaling[J]. Mol Cell Biochem. 2020 Dec;475(1-2):249-260.
[21] Dardik A, Y amashita A, Aziz F, et al. Shear stress-stimulated endothelial cells induce smooth musclecell chemotaxis via platelet-derived growth factorBB and interleukin-1alpha[J]. Physiol Heart Circ Physiol 2004;286:H1845–52.
[22] Zampetaki A, Zhang Z, Hu Y, et al. Biomechanical stress induces IL-6 expression in smooth muscle cells via Ras/Rac1-p38 MAPK-NF?B signaling pathways[J].Physiol Heart Circ Physiol 2005;288:H2946–54.
[23] H.M.Lee, H.J.Kim, H.J.et al Spleen tyrosine kinase participates in Srcmediatedmigration and proliferation by PDGF-BB in rat aortic smooth muscle cells,Arch.Pharm[J]. Res.30 (2007) 761–769.
[24] Brahmbhatt A, Remuzzi A, Franzoni M, et al. The molecular mechanisms of Hemodialysis vascular access failure[J].Kidney International,2016,89:303-316.
[25] Joshua K, Salabei,Timothy D, et al. PDGF-mediated autophagy regulates vascular smooth muscle cell phenotype and resistance to oxidative stress [J]. Biochem J, 2013, May 1; 451(3): 375–388.
[26] Wang T, Liu J, Liu H, et al. Activation of EphrinB2 Signaling Promotes Adaptive Venous Remodeling in Murine Arteriovenous Fistulae[J].Surg Res. 2021 Jun;262:224-239.
[27]Jain M,Singh A,Singh V,et al。Inhibits Serum-Induced Vascular Smooth Muscle Cell Proliferation and Injury-Induced Neointimal Hyperplasia by Suppressing p38 MAPK Activation[J]. Cardiovasc Pharmacol Ther. 2016;21(2):187-200.
[28]Cui N, Hu M, Khalil RA. Biochemical and Biological Attributes of Matrix Metalloproteinases[J].?Prog Mol Biol Transl Sci. 2017;147:1-73.?
[29]Belo VA, Guimar?es DA, Castro MM. Matrix Metalloproteinase 2 as a Potential Mediator of Vascular Smooth Muscle Cell Migration and Chronic Vascular Remodeling in Hypertension[J].Vasc Res. 2015;52(4):221-231.?
[30]Cui Y, Sun YW, Lin HS, et al. Platelet-derived growth factor-BB induces matrix metalloproteinase-2 expression and rat vascular smooth muscle cell migration via ROCK and ERK/p38 MAPK pathways[J].?Mol Cell Biochem. 2014;393(1-2):255-263
[31]Yu L, Huang X, Huang K, et al. Ligustrazine attenuates the platelet-derived growth factor-BB-induced proliferation and migration of vascular smooth muscle cells by interrupting extracellular signal-regulated kinase and P38 mitogen-activated protein kinase pathways[J].?Mol Med Rep. 2015;12(1):705-711.?
[32] Pei H, Zhang H, Tian C, et al. Proliferative Vascular Smooth Muscle Cells Stimulate Extracellular Matrix Production via Osteopontin/p38 MAPK Signaling Pathway[J].Cardiology. 2021;146(5):646-655.
[33] Sturtzel C. Endothelial Cells[J]. Adv Exp Med Biol. 2017;1003:71-91.
[34] Godo S, Shimokawa H. Endothelial Functions[J].?Arterioscler Thromb Vasc Biol. 2017;37(9):e108-e114.
[35] Corre I, Paris F, Huot J. The p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells[J]. Oncotarget. 2017 May 29;8(33):55684-55714.
[36]Wu Y, Su SA, Xie Y, et al. Murine models of vascular endothelial injury: Techniques andpathophysiology[J].?Thromb Res. 2018;169:64-72.
[37]Xu S, Ilyas I, Little PJ, et al. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies[J].?Pharmacol Rev. 2021;73(3):924-967.?
[38] Chen Y, Chen Y, Tang C, et al. RPS4Y1 Promotes High Glucose-Induced Endothelial Cell Apoptosis and Inflammation by Activation of the p38 MAPK Signaling[J]. Diabetes Metab Syndr Obes. 2021 Nov12 ; 14:4523-4534.
[39] Gong L, Lei Y, Liu Y, et al. Vaccarin prevents ox-LDL-induced HUVEC EndMT, inflammation and apoptosis by suppressing ROS/p38 MAPK signaling[J].Transl Res. 2019;11(4):2140-2154.
[40] Xiao S,Chen F,Gao C． Antitumor activity of 4-O-Methylhonokiol in human oral cancer cells is mediated via ROS generation,disruption of mitochondrial potential,cell cycle arrest and modulation of Bcl-2 / Bax proteins〔J〕.BUON,2017;22(6):1577-81.
[41] Lang HL,Hu GW,Zhang B,et al. Glioma cells enhance angiogenesis and inhibit endothelial cell apoptosis through the release of exosomes that contain long non-coding RNA CCAT2〔J〕. Oncol Rep,2017;38 (2):785-98.
[42] Tani M,Kamata Y,Deushi M,et al. 7-Ketocholesterol enhances leukocyte adhesion to endothelial cells via p38MAPK pathway 〔J〕. PLoS One,2018;13(7):e0200499．
[43] Li L,Tan H,Yang H,et al. Reactive oxygen species mediate heat stress-induced apoptosis via ERK dephosphorylation and Bcl-2 ubiquitination in human umbilical vein endothelial cells〔J〕. Oncotarget, 2017;8(8):12902-16．
